Axsome Looks Good On Multiple Catalysts: Fast Track Designation Eases Liquidity Concerns
June 20, 2017 at 12:27 PM EDT
Axsome Therapeutics Inc. (AXSM) has multiple catalysts coming up in the near future as it has two main drug candidates under Phase 3 testing for multiple conditions. The stock has shown strength as it gained over 12 percent in the past one month.